• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS 2 Star

Last Price$88.44Day Change (%)-0.77%
Open Price$88.77Day Change ($)-0.69
Day Range88.21–88.7752-Week Range70.95–91.66

As of Fri 07/25/2014 02:54 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Drug Companies Oppose Moves to Reimburse Off-Label Medicine

    Drug Companies Oppose Moves to Reimburse Off-Label Medicine

  2. Prozac Nation, Street Version

    Allscripts MDRX reported first-quarter results that were within the range of our expectations. We are maintaining our fair value estimate. The company generated $65 million in revenue, a 54% increase from the year-ago period. The strong revenue growth was propelled by an 81% revenue increase in the ...

  3. Research and Markets: Global Nicotine Patch Market 2014-2018

    Research and Markets: Global Nicotine Patch Market 2014-2018

  4. Research and Markets: Global Animal (Companion & Production) Healthcare Market 2014-2019 Featuring Key Companies, Zoetis, Merck, Merial, Bayer and Novartis

    Research and Markets: Global Animal (Companion & Production) Healthcare Market 2014-2019 Featuring Key Companies, Zoetis, Merck, Merial, Bayer and Novartis

  5. ADR Shares End Lower; SAP Shares Trade Actively

    ADR Shares End Lower; SAP Shares Trade Actively

  6. Research and Markets: Cancer Immunotherapy Market & Clinical Pipeline Insight 2014

    Research and Markets: Cancer Immunotherapy Market & Clinical Pipeline Insight 2014

  7. Looking for Bubbles Part One: A Statistical Approach

    Novartis NVS announced Friday that it is removing Zelnorm for irritable bowel syndrome from the U.S. market at the request of the Food and Drug Administration. We think Zelnorm could eventually return to pharmacy shelves in the United States, but we have drastically reduced our estimate of sales ...

  8. VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman

    VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.